Literature DB >> 15293289

Evidence for pathogenic heterogeneity in multiple sclerosis.

Claudia F Lucchinetti, Wolfgang Bruck, Hans Lassmann.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15293289     DOI： 10.1002/ana.20182

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  32 in total

Review 1.  Monoclonal antibodies as disease modifying therapy in multiple sclerosis.

Authors:  Erin E Longbrake; Becky J Parks; Anne H Cross
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

2.  Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease.

Authors:  S J Pittock; R L McClelland; S J Achenbach; F Konig; A Bitsch; W Brück; H Lassmann; J E Parisi; B W Scheithauer; M Rodriguez; B G Weinshenker; C F Lucchinetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Primary oligodendrocyte death does not elicit anti-CNS immunity.

Authors:  Giuseppe Locatelli; Simone Wörtge; Thorsten Buch; Barbara Ingold; Friederike Frommer; Bettina Sobottka; Martin Krüger; Khalad Karram; Claudia Bühlmann; Ingo Bechmann; Frank L Heppner; Ari Waisman; Burkhard Becher
Journal:  Nat Neurosci       Date:  2012-02-26       Impact factor: 24.884

4.  Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis.

Authors:  Joshua O Sestak; Amir Fakhari; Ahmed H Badawi; Teruna J Siahaan; Cory Berkland
Journal:  AAPS J       Date:  2014-09-06       Impact factor: 4.009

5.  B cell antigen presentation is sufficient to drive neuroinflammation in an animal model of multiple sclerosis.

Authors:  Chelsea R Parker Harp; Angela S Archambault; Julia Sim; Stephen T Ferris; Robert J Mikesell; Pandelakis A Koni; Michiko Shimoda; Christopher Linington; John H Russell; Gregory F Wu
Journal:  J Immunol       Date:  2015-04-20       Impact factor: 5.422

6.  Spatiotemporal distribution of fibrinogen in marmoset and human inflammatory demyelination.

Authors:  Nathanael J Lee; Seung-Kwon Ha; Pascal Sati; Martina Absinta; Nicholas J Luciano; Jennifer A Lefeuvre; Matthew K Schindler; Emily C Leibovitch; Jae Kyu Ryu; Mark A Petersen; Afonso C Silva; Steven Jacobson; Katerina Akassoglou; Daniel S Reich
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

Review 7.  CD8(+) T cells in multiple sclerosis.

Authors:  Aleksandar Denic; Bharath Wootla; Moses Rodriguez
Journal:  Expert Opin Ther Targets       Date:  2013-07-06       Impact factor: 6.902

8.  Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.

Authors:  P Belov; D Jakimovski; J Krawiecki; C Magnano; J Hagemeier; L Pelizzari; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

9.  Low-density lipoprotein receptor-related protein 1 is an essential receptor for myelin phagocytosis.

Authors:  Alban Gaultier; Xiaohua Wu; Natacha Le Moan; Shinako Takimoto; Gatambwa Mukandala; Katerina Akassoglou; W Marie Campana; Steven L Gonias
Journal:  J Cell Sci       Date:  2009-03-19       Impact factor: 5.285

Review 10.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.